Accuracy of Magnetic Resonance Imaging for Local Staging of Prostate Cancer: A Diagnostic Meta-analysis

European Urology

Volumn 70, Issue 2, 2016, Pages 233-245

  de Rooij, Maarten ^a   Hamoen, Esther H J ^a   Witjes, J Alfred ^a   Barentsz, Jelle O ^a   Rovers, Maroeska M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Diagnostic accuracy; Extracapsular extension; Magnetic resonance imaging; Meta analysis; Prostate cancer; Seminal vesicle invasion; Staging; Systematic review

Indexed keywords

CANCER DIAGNOSIS; CANCER STAGING; COCHRANE LIBRARY; CONFIDENCE INTERVAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; EMBASE; HUMAN; MEDICAL LITERATURE; MEDLINE; META ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; PUBLISHING; RECEIVER OPERATING CHARACTERISTIC; REFERENCE VALUE; REVIEW; SEMINAL VESICLE; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW; TUMOR INVASION; DIAGNOSTIC IMAGING; DIMENSIONAL MEASUREMENT ACCURACY; MALE; PATHOLOGY; PROCEDURES; PROSTATE; PROSTATE TUMOR;

DIMENSIONAL MEASUREMENT ACCURACY; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROSTATE; PROSTATIC NEOPLASMS; SENSITIVITY AND SPECIFICITY;

EID: 84937510793     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2015.07.029     Document Type: Review

References (95)

1. [1] Torre, L.A., Bray, F., Siegel, R.L., Ferlay, J., Lortet-Tieulent, J., Jemal, A., Global cancer statistics, 2012. CA Cancer J Clin, 2015.
2. [2] Heidenreich, A., Bastian, P.J., Bellmunt, J., et al. EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent—update 2013. Eur Urol 65 (2014), 124–137.
3. [3] Ward, J.F., Slezak, J.M., Blute, M.L., Bergstralh, E.J., Zincke, H., Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate-specific antigen testing: 15-year outcome. BJU Int 95 (2005), 751–756.
4. [4] Mullerad, M., Hricak, H., Kuroiwa, K., et al. Comparison of endorectal magnetic resonance imaging, guided prostate biopsy and digital rectal examination in the preoperative anatomical localization of prostate cancer. J Urol 174 (2005), 2158–2163.
5. [5] Moore, C.M., Robertson, N.L., Arsanious, N., et al. Image-guided prostate biopsy using magnetic resonance imaging-derived targets: a systematic review. Eur Urol 63 (2013), 125–140.
6. [6] Schoots, I.G., Roobol, M.J., Nieboer, D., Bangma, C.H., Steyerberg, E.W., Hunink, M.G., Magnetic resonance imaging-targeted biopsy may enhance the diagnostic accuracy of significant prostate cancer detection compared to standard transrectal ultrasound-guided biopsy: a systematic review and meta-analysis. Eur Urol 68 (2015), 438–450.
7. [7] Engelbrecht, M.R., Jager, G.J., Laheij, R.J., Verbeek, A.L., van Lier, H.J., Barentsz, J.O., Local staging of prostate cancer using magnetic resonance imaging: a meta-analysis. Eur Radiol 12 (2002), 2294–2302.
8. [8] Silva, R.C., Sasse, A.D., Matheus, W.E., Ferreira, U., Magnetic resonance image in the diagnosis and evaluation of extra-prostatic extension and involvement of seminal vesicles of prostate cancer: a systematic review of literature and meta-analysis. Int Braz J Urol 39 (2013), 155–166.
9. [9] Moher, D., Liberati, A., Tetzlaff, J., Altman, D.G., Group, P., Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med, 6, 2009, e1000097.
10. [10] Whiting, P.F., Rutjes, A.W., Westwood, M.E., et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 155 (2011), 529–536.
11. [11] Takwoingi Y, Deeks J. MetaDAS: a SAS macro for meta-analysis of diagnostic accuracy studies. User guide. Cochrane Diagnostic Test Accuracy Working Group; 2010. http://srdta.cochrane.org/software-development.
12. [12] Akin, O., Agildere, A.M., Ersoy, H., Ozen, H., Tekin, I., Ayhan, A., Local staging of prostate cancer with endorectal surface coil MR imaging in a mid-field magnetic system. Clin Imaging 27 (2003), 47–51.
13. [13] Akin, O., Sala, E., Moskowitz, C.S., et al. Transition zone prostate cancers: features, detection, localization, and staging at endorectal MR imaging. Radiology 239 (2006), 784–792.
14. [14] Allen, D.J., Hindley, R., Clovis, S., et al. Does body-coil magnetic-resonance imaging have a role in the preoperative staging of patients with clinically localized prostate cancer?. BJU Int 94 (2004), 534–538.
15. [15] Armitage, J.N., Igali, L., Ball, R.Y., Mills, R.D., Kumar, V., Comparison of body-array MRI and Partin tables for predicting extracapsular prostate cancer. J Clin Urol 6 (2013), 50–54.
16. [16] Augustin, H., Fritz, G.A., Ehammer, T., Auprich, M., Pummer, K., Accuracy of 3-Tesla magnetic resonance imaging for the staging of prostate cancer in comparison to the Partin tables. Acta Radiol 50 (2009), 562–569.
17. [17] Bernstein, M.R., Cangiano, T., D'Amico, A., et al. Endorectal coil magnetic resonance imaging and clinicopathologic findings in T1c adenocarcinoma of the prostate. Urol Oncol 5 (2000), 104–107.
18. [18] Beyersdorff, D., Taymoorian, K., Knosel, T., et al. MRI of prostate cancer at 1.5 and 3.0 T: comparison of image quality in tumor detection and staging. Am J Roentgenol 185 (2005), 1214–1220.
19. [19] Bloch, B.N., Furman-Haran, E., Helbich, T.H., et al. Prostate cancer: accurate determination of extracapsular extension with high-spatial-resolution dynamic contrast-enhanced and T2-weighted MR imaging—initial results. Radiology 245 (2007), 176–185.
20. [20] Bloch, B.N., Genega, E.M., Costa, D.N., et al. Prediction of prostate cancer extracapsular extension with high spatial resolution dynamic contrast-enhanced 3-T MRI. Eur Radiol 22 (2012), 2201–2210.
21. [21] Borre, M., Lundorf, E., Marcussen, N., Langkilde, N.C., Wolf, H., Phased array magnetic resonance imaging for staging clinically localized prostate cancer. Acta Oncol 44 (2005), 589–592.
22. [22] Brajtbord, J.S., Lavery, H.J., Nabizada-Pace, F., Senaratne, P., Samadi, D.B., The ability of endorectal coil MRI to preoperatively predict seminal vesicle invasion. Int J Med Robot Comput Assist Surg 7 (2011), 28–29.
23. [23] Brassell, S.A., Krueger, W.R., Choi, J.H., Taylor, J.A. 3rd, Correlation of endorectal coil magnetic resonance imaging of the prostate with pathologic stage. World J Urol 22 (2004), 289–292.
24. [24] Brown, J.A., Rodin, D.M., Harisinghani, M., Dahl, D.M., Impact of preoperative endorectal MRI stage classification on neurovascular bundle sparing aggressiveness and the radical prostatectomy positive margin rate. Urol Oncol 27 (2009), 174–179.
25. [25] Cerantola, Y., Valerio, M., Kawkabani Marchini, A., Meuwly, J.Y., Jichlinski, P., Can 3 T multiparametric magnetic resonance imaging accurately detect prostate cancer extracapsular extension?. Can Urol Assoc J 7 (2013), E699–E703.
26. [26] Chandra, R.V., Heinze, S., Dowling, R., Shadbolt, C., Costello, A., Pedersen, J., Endorectal magnetic resonance imaging staging of prostate cancer. ANZ J Surg 77 (2007), 860–865.
27. [27] Chong, Y., Kim, C.K., Park, S.Y., Park, B.K., Kwon, G.Y., Park, J.J., Value of diffusion-weighted imaging at 3 T for prediction of extracapsular extension in patients with prostate cancer: a preliminary study. Am J Roentgenol 202 (2014), 772–777.
28. [28] Cornud, F., Flam, T., Chauveinc, L., et al. Extraprostatic spread of clinically localized prostate cancer: factors predictive of pT3 tumor and of positive endorectal MR imaging examination results. Radiology 224 (2002), 203–210.
29. [29] Cornud, F., Hamida, K., Flam, T., et al. Endorectal color Doppler sonography and endorectal MR imaging features of nonpalpable prostate cancer: correlation with radical prostatectomy findings. Am J Roentgenol 175 (2000), 1161–1168.
30. [30] Cornud, F., Rouanne, M., Beuvon, F., et al. Endorectal 3D T2-weighted 1mm-slice thickness MRI for prostate cancer staging at 1.5 Tesla: should we reconsider the indirects signs of extracapsular extension according to the D'Amico tumor risk criteria?. Eur J Radiol 81 (2012), e591–e597.
31. [31] Counago, F., Recio, M., Del Cerro, E., et al. Role of 3.0 T multiparametric MRI in local staging in prostate cancer and clinical implications for radiation oncology. Clin Transl Oncol 16 (2014), 993–999.
32. [32] Futterer, J.J., Engelbrecht, M.R., Huisman, H.J., et al. Staging prostate cancer with dynamic contrast-enhanced endorectal MR imaging prior to radical prostatectomy: experienced versus less experienced readers. Radiology 237 (2005), 541–549.
33. [33] Futterer, J.J., Engelbrecht, M.R., Jager, G.J., et al. Prostate cancer: comparison of local staging accuracy of pelvic phased-array coil alone versus integrated endorectal-pelvic phased-array coils. Eur Radiol 17 (2007), 1055–1065.
34. [34] Futterer, J.J., Heijmink, S.W., Scheenen, T.W., et al. Prostate cancer: local staging at 3-T endorectal MR imaging—early experience. Radiology 238 (2006), 184–191.
35. [35] Graser, A., Heuck, A., Sommer, B., et al. Per-sextant localization and staging of prostate cancer: correlation of imaging findings with whole-mount step section histopathology. Am J Roentgenol 188 (2007), 84–90.
36. [36] Gupta, R.T., Faridi, K.F., Singh, A.A., et al. Comparing 3-T multiparametric MRI and the Partin tables to predict organ-confined prostate cancer after radical prostatectomy. Urol Oncol 32 (2014), 1292–1299.
37. [37] Hara, T., Nakanishi, H., Nakagawa, T., et al. Ability of preoperative 3.0-Tesla magnetic resonance imaging to predict the absence of side-specific extracapsular extension of prostate cancer. Int J Urol 20 (2013), 993–999.
38. [38] Hegde, J.V., Chen, M.H., Mulkern, R.V., Fennessy, F.M., D'Amico, A.V., Tempany, C.M., Preoperative 3-Tesla multiparametric endorectal magnetic resonance imaging findings and the odds of upgrading and upstaging at radical prostatectomy in men with clinically localized prostate cancer. Int J Radiat Oncol Biol Phys 85 (2013), e101–e107.
39. [39] Heijmink, S.W., Futterer, J.J., Hambrock, T., et al. Prostate cancer: body-array versus endorectal coil MR imaging at 3 T—comparison of image quality, localization, and staging performance. Radiology 244 (2007), 184–195.
40. [40] Hole, K.H., Axcrona, K., Lie, A.K., et al. Routine pelvic MRI using phased-array coil for detection of extraprostatic tumour extension: accuracy and clinical significance. Eur Radiol 23 (2013), 1158–1166.
41. [41] Ko, Y.H., Sung, D.J., Kang, S.G., et al. The predictability of T3 disease in staging MRI following prostate biopsy decreases in patients with high initial PSA and Gleason score. Asian J Androl 13 (2011), 487–493.
42. [42] Ikonen, S., Karkkainen, P., Kivisaari, L., et al. Endorectal magnetic resonance imaging of prostatic cancer: comparison between fat-suppressed T2-weighted fast spin echo and three-dimensional dual-echo, steady-state sequences. Eur Radiol 11 (2001), 236–241.
43. [43] Jeong, I.G., Lim, J.H., You, D., et al. Incremental value of magnetic resonance imaging for clinically high risk prostate cancer in 922 radical prostatectomies. J Urol 190 (2013), 2054–2060.
44. [44] Johnston, R., Wong, L.M., Warren, A., Shah, N., Neal, D., The role of 1.5 Tesla magnetic resonance imaging in staging prostate cancer. ANZ J Surg 83 (2013), 234–238.
45. [45] Jung, D.C., Lee, H.J., Kim, S.H., Choe, G.Y., Lee, S.E., Preoperative MR imaging in the evaluation of seminal vesicle invasion in prostate cancer: pattern analysis of seminal vesicle lesions. J Magn Reson Imaging 28 (2008), 144–150.
46. [46] Kim, B., Breau, R.H., Papadatos, D., et al. Diagnostic accuracy of surface coil magnetic resonance imaging at 1.5 T for local staging of elevated risk prostate cancer. Can Urol Assoc J 4 (2010), 257–262.
47. [47] Kim, B.S., Kim, T.H., Kwon, T.G., Yoo, E.S., Comparison of pelvic phased-array versus endorectal coil magnetic resonance imaging at 3 Tesla for local staging of prostate cancer. Yonsei Med J 53 (2012), 550–556.
48. [48] Kim, C.K., Choi, D., Park, B.K., Kwon, G.Y., Lim, H.K., Diffusion-weighted MR imaging for the evaluation of seminal vesicle invasion in prostate cancer: initial results. J Magn Reson Imaging 28 (2008), 963–969.
49. [49] Kwek, J.W., Thng, C.H., Tan, P.H., et al. Phased-array magnetic resonance imaging of the prostate with correlation to radical prostatectomy specimens: local experience. Asian J Surg 27 (2004), 219–224.
50. [50] Latchamsetty, K.C., Borden, L.S. Jr., Porter, C.R., et al. Experience improves staging accuracy of endorectal magnetic resonance imaging in prostate cancer: what is the learning curve?. Can J Urol 14 (2007), 3429–3434.
51. [51] Lee, S.H., Park, K.K., Choi, K.H., et al. Is endorectal coil necessary for the staging of clinically localized prostate cancer? Comparison of non-endorectal versus endorectal MR imaging. World J Urol 28 (2010), 667–672.
52. [52] May, F., Treumann, T., Dettmar, P., Hartung, R., Breul, J., Limited value of endorectal magnetic resonance imaging and transrectal ultrasonography in the staging of clinically localized prostate cancer. BJU Int 87 (2001), 66–69.
53. [53] Min, B.D., Kim, W.T., Cho, B.S., et al. Usefulness of a combined approach of T1-weighted, T2-weighted, dynamic contrast-enhanced, and diffusion-weighted imaging in prostate cancer. Korean J Urol 53 (2012), 830–835.
54. [54] Nakashima, J., Tanimoto, A., Imai, Y., et al. Endorectal MRI for prediction of tumor site, tumor size, and local extension of prostate cancer. Urology 64 (2004), 101–105.
55. [55] Nepple, K.G., Rosevear, H.M., Stolpen, A.H., Brown, J.A., Williams, R.D., Concordance of preoperative prostate endorectal MRI with subsequent prostatectomy specimen in high-risk prostate cancer patients. Urol Oncol 31 (2013), 601–606.
56. [56] Ogura, K., Maekawa, S., Okubo, K., et al. Dynamic endorectal magnetic resonance imaging for local staging and detection of neurovascular bundle involvement of prostate cancer: correlation with histopathologic results. Urology 57 (2001), 721–726.
57. [57] Oon, S.F., Power, S.P., Kelly, J.S., McDermott, V., Ryan, P., Ryan, P.C., The accuracy of magnetic resonance imaging in prostate cancer staging: a single-institution experience. Ir J Med Sci 184 (2015), 313–317.
58. [58] Otto, J., Thormer, G., Seiwerts, M., et al. Value of endorectal magnetic resonance imaging at 3T for the local staging of prostate cancer. Rofo 186 (2014), 795–802.
59. [59] Park, B.H., Choo, S.H., Jang, H.J., et al. Accuracy of phased-array 3.0-T MR imaging in predicting extracapsular extension and influence on the decision to preserve neurovascular bundles at robotic assisted laparoscopic radical prostatectomy. Eur Urol Suppl, 12, 2013, e297.
60. [60] Park, B.K., Kim, B., Kim, C.K., Lee, H.M., Kwon, G.Y., Comparison of phased-array 3.0-T and endorectal 1.5-T magnetic resonance imaging in the evaluation of local staging accuracy for prostate cancer. J Comput Assist Tomogr 31 (2007), 534–538.
61. [61] Park, S.Y., Kim, J.J., Kim, T.H., et al. The role of endorectal magnetic resonance imaging in predicting extraprostatic extension and seminal vesicle invasion in clinically localized prostate cancer. Korean J Urol 51 (2010), 308–312.
62. [62] Porcaro, A.B., Borsato, A., Romano, M., et al. Accuracy of preoperative endo-rectal coil magnetic resonance imaging in detecting clinical under-staging of localized prostate cancer. World J Urol 31 (2013), 1245–1251.
63. [63] Pugh, T.J., Frank, S.J., Achim, M., et al. Endorectal magnetic resonance imaging for predicting pathologic T3 disease in Gleason score 7 prostate cancer: Implications for prostate brachytherapy. Brachytherapy 12 (2013), 204–209.
64. [64] Ren, J., Huan, Y., Wang, H., et al. Seminal vesicle invasion in prostate cancer: prediction with combined T2-weighted and diffusion-weighted MR imaging. Eur Radiol 19 (2009), 2481–2486.
65. [65] Renard-Penna, R., Roupret, M., Comperat, E., et al. Accuracy of high resolution (1.5 Tesla) pelvic phased array magnetic resonance imaging (MRI) in staging prostate cancer in candidates for radical prostatectomy: results from a prospective study. Urol Oncol 31 (2013), 448–454.
66. [66] Roethke, M., Kaufmann, S., Kniess, M., et al. Seminal vesicle invasion: accuracy and analysis of infiltration patterns with high-spatial resolution T2-weighted sequences on endorectal magnetic resonance imaging. Urol Int 92 (2014), 294–299.
67. [67] Roethke, M.C., Lichy, M.P., Kniess, M., et al. Accuracy of preoperative endorectal MRI in predicting extracapsular extension and influence on neurovascular bundle sparing in radical prostatectomy. World J Urol 31 (2013), 1111–1116.
68. [68] Rosenkrantz, A.B., Chandarana, H., Gilet, A., et al. Prostate cancer: utility of diffusion-weighted imaging as a marker of side-specific risk of extracapsular extension. J Magn Reson Imaging 38 (2013), 312–319.
69. [69] Rud, E., Klotz, D., Rennesund, K., et al. Preoperative magnetic resonance imaging for detecting uni- and bilateral extraprostatic disease in patients with prostate cancer. World J Urol 33 (2015), 1015–1021.
70. [70] Ruprecht, O., Weisser, P., Bodelle, B., Ackermann, H., Vogl, T.J., MRI of the prostate: interobserver agreement compared with histopathologic outcome after radical prostatectomy. Eur J Radiol 81 (2012), 456–460.
71. [71] Sala, E., Akin, O., Moskowitz, C.S., et al. Endorectal MR imaging in the evaluation of seminal vesicle invasion: diagnostic accuracy and multivariate feature analysis. Radiology 238 (2006), 929–937.
72. [72] Somford, D.M., Hamoen, E.H., Futterer, J.J., et al. The predictive value of endorectal 3 Tesla multiparametric magnetic resonance imaging for extraprostatic extension in patients with low, intermediate and high risk prostate cancer. J Urol 190 (2013), 1728–1734.
73. [73] Soulie, M., Aziza, R., Escourrou, G., et al. Assessment of the risk of positive surgical margins with pelvic phased-array magnetic resonance imaging in patients with clinically localized prostate cancer: a prospective study. Urology 58 (2001), 228–232.
74. [74] Soylu, F.N., Peng, Y., Jiang, Y., et al. Seminal vesicle invasion in prostate cancer: evaluation by using multiparametric endorectal MR imaging. Radiology 267 (2013), 797–806.
75. [75] Tan, J.S., Thng, C.H., Tan, P.H., et al. Local experience of endorectal magnetic resonance imaging of prostate with correlation to radical prostatectomy specimens. Ann Acad Med Singapore 37 (2008), 40–43.
76. [76] Tanaka, K., Shigemura, K., Muramaki, M., Takahashi, S., Miyake, H., Fujisawa, M., Efficacy of using three-Tesla magnetic resonance imaging diagnosis of capsule invasion for decision-making about neurovascular bundle preservation in robotic-assisted radical prostatectomy. Korean J Urol 54 (2013), 437–441.
77. [77] Torricelli, P., Barberini, A., Cinquantini, F., Sighinolfi, M., Cesinaro, A.M., 3-T MRI with phased-array coil in local staging of prostatic cancer. Acad Radiol 15 (2008), 1118–1125.
78. [78] Torricelli, P., Cinquantini, F., Ligabue, G., Bianchi, G., Sighinolfi, P., Romagnoli, R., Comparative evaluation between external phased array coil at 3 T and endorectal coil at 1.5 T: preliminary results. J Comput Assist Tomogr 30 (2006), 355–361.
79. [79] Tsao, C.W., Lin, M.H., Wu, S.T., et al. Combining prostrate-specific antigen and Gleason score increases the diagnostic power of endorectal coil magnetic resonance imaging in prostate cancer pathological stage. J Chin Med Assoc 76 (2013), 20–24.
80. [80] Wang, J.G., Huang, J., Chin, A.I., RARP in high-risk prostate cancer: use of multi-parametric MRI and nerve sparing techniques. Asian J Androl 16 (2014), 715–719.
81. [81] Wang, L., Mullerad, M., Chen, H.N., et al. Prostate cancer: incremental value of endorectal MR imaging findings for prediction of extracapsular extension. Radiology 232 (2004), 133–139.
82. [82] Wang, L., Zhang, J., Schwartz, L.H., et al. Incremental value of multiplanar cross-referencing for prostate cancer staging with endorectal MRI. Am J Roentgenol 188 (2007), 99–104.
83. [83] Wetter, A., Engl, T.A., Nadjmabadi, D., et al. Combined MRI and MR spectroscopy of the prostate before radical prostatectomy. Am J Roentgenol 187 (2006), 724–730.
84. [84] Xylinas, E., Yates, D.R., Renard-Penna, R., et al. Role of pelvic phased array magnetic resonance imaging in staging of prostate cancer specifically in patients diagnosed with clinically locally advanced tumours by digital rectal examination. World J Urol 31 (2013), 881–886.
85. [85] Zhang, J., Hricak, H., Shukla-Dave, A., et al. Clinical stage T1c prostate cancer: evaluation with endorectal MR imaging and MR spectroscopic imaging. Radiology 253 (2009), 425–434.
86. [86] Zhang, J.Q., Loughlin, K.R., Zou, K.H., Haker, S., Tempany, C.M., Role of endorectal coil magnetic resonance imaging in treatment of patients with prostate cancer and in determining radical prostatectomy surgical margin status: report of a single surgeon's practice. Urology 69 (2007), 1134–1137.
87. [87] Deeks, J.J., Macaskill, P., Irwig, L., The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. J Clin Epidemiol 58 (2005), 882–893.
88. [88] Barentsz, J.O., Richenberg, J., Clements, R., et al. ESUR prostate MR guidelines 2012. Eur Radiol 22 (2012), 746–757.
89. [89] Futterer, J.J., Barentsz, J.O., Heijmink, S.W., Value of 3-T magnetic resonance imaging in local staging of prostate cancer. Top Magn Reson Imaging 19 (2008), 285–289.
90. 18F-fluorocholine positron emission tomography (PET) and PET/CT in prostate cancer: a systematic review and meta-analysis. Eur Urol 64 (2013), 106–117.
91. [91] Wibmer, A., Vargas, H.A., Sosa, R., Zheng, J., Moskowitz, C., Hricak, H., Value of a standardized lexicon for reporting levels of diagnostic certainty in prostate MRI. Am J Roentgenol 203 (2014), W651–W657.
92. [92] Hamoen, E.H., de Rooij, M., Witjes, J.A., Barentsz, J.O., Rovers, M.M., Use of the prostate imaging reporting and data system (PI-RADS) for prostate cancer detection with multiparametric magnetic resonance imaging: a diagnostic meta-analysis. Eur Urol 67 (2015), 1112–1121.
93. [93] Chuang, A.Y., Nielsen, M.E., Hernandez, D.J., Walsh, P.C., Epstein, J.I., The significance of positive surgical margin in areas of capsular incision in otherwise organ confined disease at radical prostatectomy. J Urol 178 (2007), 1306–1310.
94. [94] Wheeler, T.M., Dillioglugil, O., Kattan, M.W., et al. Clinical and pathological significance of the level and extent of capsular invasion in clinical stage T1–2 prostate cancer. Hum Pathol 29 (1998), 856–862.
95. [95] Fine, S.W., Amin, M.B., Berney, D.M., et al. A contemporary update on pathology reporting for prostate cancer: biopsy and radical prostatectomy specimens. Eur Urol 62 (2012), 20–39.